Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublication note wording changed to indicate publications are automatically filled from PubMed, and the Revision tag was updated to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded Tainan, Taiwan as a study site. Removed the Tainan City, Taiwan listing and the government-funding status notice from the page.SummaryDifference0.2%

- Check42 days agoChange DetectedNo significant changes were detected on the Study Details page for NCT03673501. The content, locations, and eligibility criteria appear unchanged.SummaryDifference0.2%

- Check71 days agoChange Detected- Updated version to v3.2.0 and removed the Gastrointestinal stromal tumor resource from Genetic and Rare Diseases Information Center. - Added a government funding lapse notice with operating-status guidance for users.SummaryDifference2%

- Check78 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0 to reflect a newer release.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdate to Revision: v3.0.2 from v3.0.1; removal of 'Back to Top' is a minor UI change and does not affect core content.SummaryDifference0.1%

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.